My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 499

    1.

    Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function.

    Fernández-Real JM, Peñarroja G, Castro A, García-Bragado F, Hernández-Aguado I, Ricart W.

    Diabetes. 2002 Apr;51(4):1000-4.PMID: 11916918 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity.

    Fernández-Real JM, Peñarroja G, Castro A, García-Bragado F, López-Bermejo A, Ricart W.

    Diabetes Care. 2002 Dec;25(12):2249-55.PMID: 12453969 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.

    Amoah AG, Owusu SK, Schuster DP, Osei K.

    S Afr Med J. 2002 May;92(5):377-84.PMID: 12108171 [PubMed - indexed for MEDLINE]Related articles

    4.

    Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: new insights on mechanisms of action.

    Osei K, Rhinesmith S, Gaillard T, Schuster D.

    Metabolism. 2003 May;52(5):565-72.PMID: 12759885 [PubMed - indexed for MEDLINE]Related articles

    5.

    Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

    Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

    Clin Ther. 2005 Sep;27(9):1383-91.PMID: 16291411 [PubMed - indexed for MEDLINE]Related articles

    6.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    7.

    C-peptide and glucagon profiles in minority children with type 2 diabetes mellitus.

    Umpaichitra V, Bastian W, Taha D, Banerji MA, AvRuskin TW, Castells S.

    J Clin Endocrinol Metab. 2001 Apr;86(4):1605-9.PMID: 11297591 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.

    Osei K, Gaillard T, Schuster D.

    Metabolism. 2007 Jan;56(1):24-9.PMID: 17161222 [PubMed - indexed for MEDLINE]Related articles

    9.

    Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent.

    Lirussi F, Beccarello A, Zanette G, De Monte A, Donadon V, Velussi M, Crepaldi G.

    Diabetes Nutr Metab. 2002 Aug;15(4):222-31.PMID: 12416659 [PubMed - indexed for MEDLINE]Related articles

    10.

    Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".

    Banerji MA.

    J Pediatr Endocrinol Metab. 2002 Apr;15 Suppl 1:493-501. Review.PMID: 12017222 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of high protein vs high carbohydrate intake on insulin sensitivity, body weight, hemoglobin A1c, and blood pressure in patients with type 2 diabetes mellitus.

    Sargrad KR, Homko C, Mozzoli M, Boden G.

    J Am Diet Assoc. 2005 Apr;105(4):573-80.PMID: 15800559 [PubMed - indexed for MEDLINE]Related articles

    12.

    Factors affecting glucose tolerance in hereditary hemochromatosis.

    Hramiak IM, Finegood DT, Adams PC.

    Clin Invest Med. 1997 Apr;20(2):110-8.PMID: 9088667 [PubMed - indexed for MEDLINE]Related articles

    13.

    Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year.

    Ahrén B, Pacini G, Foley JE, Schweizer A.

    Diabetes Care. 2005 Aug;28(8):1936-40.PMID: 16043735 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

    Roberts VL, Stewart J, Issa M, Lake B, Melis R.

    Clin Ther. 2005 Oct;27(10):1535-47.PMID: 16330290 [PubMed - indexed for MEDLINE]Related articles

    15.

    Type 2 diabetes mellitus in African-American adolescents: impaired beta-cell function in the face of severe insulin resistance.

    Taha D, Umpaichitra V, Banerji MA, Castells S.

    J Pediatr Endocrinol Metab. 2006 Feb;19(2):135-42.PMID: 16562586 [PubMed - indexed for MEDLINE]Related articles

    16.

    Beneficial metabolic effects of chronic glipizide in obese African Americans with impaired glucose tolerance: implications for primary prevention of type 2 diabetes.

    Osei K, Rhinesmith S, Gaillard T, Schuster D.

    Metabolism. 2004 Apr;53(4):414-22.PMID: 15045685 [PubMed - indexed for MEDLINE]Related articles

    17.

    Clinical expression and insulin sensitivity in type 2 diabetic patients with heterozygous mutations for haemochromatosis.

    Van Lerberghe S, Hermans MP, Dahan K, Buysschaert M.

    Diabetes Metab. 2002 Feb;28(1):33-8.PMID: 11938026 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.

    Mattoo V, Eckland D, Widel M, Duran S, Fajardo C, Strand J, Knight D, Grossman L, Oakley D, Tan M; H6E-MC-GLAT study group.

    Clin Ther. 2005 May;27(5):554-67.PMID: 15978304 [PubMed - indexed for MEDLINE]Related articles

    19.

    Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions.

    Bolli GB, Tsalikian E, Haymond MW, Cryer PE, Gerich JE.

    J Clin Invest. 1984 Jun;73(6):1532-41.PMID: 6373827 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapy.

    Davidson JA, McMorn SO, Waterhouse BR, Cobitz AR.

    Clin Ther. 2007 Sep;29(9):1900-14.PMID: 18035190 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity